National and Kapodistrian University of Athens
Μη επεμβατική προγεννητική διάγνωση αιμοσφαιρινοπαθειών με χρήση δεικτών μοριακής βιολογίας
Abstract
dc:descriptionThe presence of free nucleic acids in the peripheral circulationhas been known since 1948. However no research on this area wascarried out at the time of the discovery due to the lack of sufficientlyadvanced technology.The first results regarding the clinical value of free nucleic acidscame to light in the literature 30 years after their original discovery. Thiswas first reported in studies of autoimmune disorders in which themechanism of their release in the peripheral blood was studied as wellas their potential role in the sensitization of the immune system and anypossible correlation between their concentration and the clinicaloutcome. Interest was intensified when in 1977 Leon et al announcedthat levels of cell free DNA may have some clinical prognostic value forthe severity of cancer in suffering patients.Presently there is great research effort worldwide in progress toutilize the cell free fetal DNA as material for non-invasive PrenatalDiagnosis for inherited disorders, or as a prognostic marker forpathological conditions (i.e. aneuploidies and proeclampsia) in high riskpregnancies.The eventual outcome of these efforts will also have an effect ontesting of the monogenic inherited disorders such as thalassemia majorand cystic fibrosis.Efforts have focused, for this reason, in the development of quicksensitive and low cost protocols for both qualitative and quantitativedetection. The protocol design is of great importance in order to achievethe detection of circulating fetal material and overcome the technical difficulties that we are facing today.In many European countries, including Greece, sex determinationand RhD status are carried out with non-invasive techniques on aroutine basis by Government laboratories using as starting materialplasma from maternal peripheral blood.In the present study, after testing several existing technologies, asensitive and reliable Polymerase Chain Reaction was developed withLNA modified primers and detection by Fragment Analysis fluorescentPCR for detecting paternally inherited mutations in the ffDNA. As amodel disease we used thalassemia major.Advantages of the method include the rapid analysis andprocessing of the results and the high sensitivity of the reaction that candetect 6.6 pg of fetal DNA in the maternal sample.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimisianos, Gerasimos
- Δημησιανός, Γεράσιμος
Subjects
dc:subject × 14- Μη επεμβατική προγεννητική διάγνωση
- Ελεύθερο DNA
- Ελεύθερο εμβρυϊκό DNA
- Αιμοσφαιρινοπάθειες
- Κλειδωμένα νουκλεικά οξέα
- Non invasive prenatal diagnosis
- Free DNA
- Free fetal DNA
- Haemoglobinopathies
- Cocked nucleic ACID
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40302